Anti-Trichomonas vaginalis Activity of Biogenic Apigenin-Functionalized Gold Nanoparticle
Abstract
Background: Trichomonas vaginalis, a flagellated protozoan parasite, causes human trichomoniasis, a prevalent sexually transmitted infection worldwide. Although metronidazole remains standard therapy, rising drug resistance, side effects, and potential teratogenic risks highlight the urgent need for safer alternatives. In this study, apigenin-functionalized gold nanoparticles (Api@AuNPs) were synthesized and their cytotoxic effects on T. vaginalis trophozoites were evaluated.
Methods: This study was conducted in 2025 at the Department of Parasitology and Mycology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Api@AuNPs were synthesized via chemical reduction, purified by high-speed centrifugation, and characterized using UV–Vis spectroscopy, TEM, DLS/zeta analysis, and ICP-OES. A clinically confirmed Trichomonas isolate was cultured and treated with varying concentrations of nanoparticles (16–1500 μg/mL) or metronidazole (1.62–250 μg/mL) for 24 and 48 hours. Cytotoxicity was assessed by determining CC₅₀ values at both time points using probit regression analysis.
Results: These results demonstrated that Api@AuNPs, were synthesized and characterized by a distinct SPR peak, spherical morphology, and a favorable zeta potential. Cytotoxicity analysis demonstrated that Api@AuNPs reduced the viability of parasite trophozoites in a time-dependent manner, with CC₅₀ values decreasing from 267.29 μg/mL at 24 hours to 173.90 μg/mL at 48 hours. Although metronidazole displayed greater potency, with corresponding CC₅₀ values of 107.09 μg/mL and 74.93 μg/mL, the progressive enhancement of Api@AuNP activity over time highlights its therapeutic potential.
Conclusion: Api@AuNPs showed time-dependent in vitro activity against Trichomonas vaginalis. These findings suggest their potential for further investigation, although additional in vitro, in vivo, and safety studies are required before therapeutic application can be considered.
2. Bairami A, Kabir K, Alaei BA, et al. Prevalence and clinical aspects of Trichomonas vaginalis infection among high-risk women in Karaj, Iran. Iran J Parasitol. 2024;19(4):475–479.
3. Ziaei Hezarjaribi H, Fakhar M, Shokri A, et al. Trichomonas vaginalis infection among Iranian general population of women: A systematic review and meta-analysis. Parasitol Res. 2015;114(4):1291-1300.
4. Altememy D, Jafari M, Naeini K, et al. In-vitro evaluation of metronidazole loaded mesoporous silica nanoparticles against Trichomonas vaginalis. Int J Pharm Res. 2020;12:2773–2780.
5. Sobel R, Sobel JD. Metronidazole for the treatment of vaginal infections. Expert Opin Pharmacother. 2015;16(7):1109-1115.
6. Fonseca-Silva F, Canto-Cavalheiro MM, Menna-Barreto RF, et al. Effect of apigenin on Leishmania amazonensis is associated with reactive oxygen species production followed by mitochondrial dysfunction. J Nat Prod. 2015;78(4):880-884.
7. Fonseca-Silva F, Inacio JD, Canto-Cavalheiro MM, et al. Oral efficacy of apigenin against cutaneous leishmaniasis: Involvement of reactive oxygen species and autophagy as a mechanism of action. PLoS Negl Trop Dis. 2016;10(2):e0004442.
8. Emiliano YS, Almeida-Amaral EE. Apigenin is a promising molecule for treatment of visceral leishmaniasis. Front Cell Infect Microbiol. 2023;13:1066407.
9. Naddaf N, Haddad S. Apigenin effect against Leishmania tropica amastigotes in vitro. J Parasit Dis. 2020;44(3):574-578.
10. Jafari M, Badirzadeh A, Fazeli N, et al. In vitro evaluation of apigenin-coated silver nanoparticles against Trichomonas vaginalis: A potential alternative to metronidazole. Nanomed Res J. 2025;10(1):51-58.
11. Raziani Y, Shakib P, Rashidipour M, Cheraghipour K, Ghasemian Yadegari J, Mahmoudvand H. Green synthesis, characterization, and antiparasitic effects of gold nanoparticles against Echinococcus granulosus protoscoleces. Trop Med Infect Dis. 2023;8(6):313-324.
12. Roy P, Saha SK, Gayen P, et al. Exploration of antifilarial activity of gold nanoparticle against human and bovine filarial parasites: A nanomedicinal mechanistic approach. Colloids Surf B Biointerfaces. 2018; 161:236-243.
13. Raj S, Sasidharan S, Tripathi T, et al. Biofunctionalized chrysin-conjugated gold nanoparticles neutralize Leishmania parasites with high efficacy. Int J Biol Macromol. 2022;205:211-219.
14. Mohammadi E, Amini SM. Green synthesis of stable and biocompatible silver nanoparticles with natural flavonoid apigenin. Nano-Struct Nano-Objects. 2024;38:101175.
15. Mahabadi VP, Amini SM, Jameie SB, et al. A study of sleep-wake cycle after transplantation of neural stem cells treated with gold nanoparticles in the suprachiasmatic nucleus lesion in the rat. Nanomed Res J. 2025;9(3):308-316.
16. Neshastehriz A, Hormozi-Moghaddam Z, Amini SM, et al. Combined sonodynamic therapy and x-ray radiation with methylene blue and gold nanoparticles coated with apigenin: Impact on mcf7 cell viability. Int J Radiat Res. 2024;22(2):509-513.
17. Amini SM, Mohammadi E, Askarian‐Amiri S, et al. Investigating the in vitro photothermal effect of green synthesized apigenin‐coated gold nanoparticle on colorectal carcinoma. IET Nanobiotechnol. 2021;15(3):329-337.
18. Altememy D, Jafari M, Naeini K, et al. In-vitro evaluation of metronidazole loaded mesoporous silica nanoparticles against Trichomonas vaginalis . Int J Pharm Res. 2020;12:2773-2780.
19. Heidary S, Bandehpour M, Valadkhani Z, et al. Double-stranded RNA viral infection in Tehran Trichomonas vaginalis isolates. Iran J Parasitol. 2013;8(1):60-64.
20. Jafari M, Amini-Khoei H, Cheshmpanam M, et al. A survey on the anti-Trichomonas vaginalis effect of the hydroalcoholic extract of various medicinal plants in vitro. J Shahrekord Univ Med Sci. 2022;25(1):1-6.
21. Menezes CB, Frasson AP, Tasca T. Trichomoniasis-are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide? Microb Cell. 2016;3(9):404–419.
22. Mercer F, Johnson PJ. Trichomonas vaginalis: Pathogenesis, symbiont interactions, and host cell immune responses. Trends Parasitol. 2018;34(8):683-693.
23. Meingassner JG, Thurner J. Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles. Antimicrob Agents Chemother. 1979; 15(2):254-257.
24. Amini SM, Kharrazi S, Rezayat SM, et al. Radiofrequency electric field hyperthermia with gold nanostructures: Role of particle shape and surface chemistry. Artif Cells Nanomed Biotechno. 2018;46(7):1452-1462.
25. Amendola V, Meneghetti M. Size evaluation of gold nanoparticles by UV−vis spectroscopy. J Phys Chem C. 2009; 113(11):4277-4285.
26. Alhadrami HA, Orfali R, Hamed AA, et al. Flavonoid-coated gold nanoparticles as efficient antibiotics against gram-negative bacteria—evidence from in silico-supported in vitro studies. Antibiotics. 2021;10(8):968-985.
27. Roy P, Parveen S, Ghosh P, et al. Flavonoid loaded nanoparticles as an effective measure to combat oxidative stress in ribonuclease a. Biochimie. 2019;162:185-197.
28. Ginwala R, Bhavsar R, Chigbu DGI, et al. Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin. Antioxidants. 2019;8(2):35-63.
29. Yan X, Qi M, Li P, et al. Apigenin in cancer therapy: Anti-cancer effects and mechanisms of action. Cell Biosci. 2017; 7(1):50-66.
30. AbouLaila MR, Rizk M, Abdel Aziz A, et al. Evaluation of the in vitro and in vivo inhibitory effects of apigenin and gallic acid on the growth of Babesia and Theileria parasites. Egypt Vet Med Soci Parasitol J. 2018;14:137-150.
31. Amiri M, Nourian A, Khoshkam M, et al. Apigenin inhibits growth of the Plasmodium berghei and disrupts some metabolic pathways in mice. Phytother Res. 2018;32(9):1795-1802.
32. Mehriardestani M, Aliahmadi A, Toliat T, et al. Medicinal plants and their isolated compounds showing anti-Trichomonas vaginalis -activity. Biomed Pharmacother. 2017;88:885-893.
33. Ngernyuang N, Wongwattanakul M, Charusirisawad W, et al. Green synthesized apigenin conjugated gold nanoparticles inhibit cholangiocarcinoma cell activity and endothelial cell angiogenesis in vitro. Heliyon. 2022;8(12);e12028.
34. Badirzadeh A, Jaffari M, Amini SM. Antiparasitic potential of eco-synthesized curcumin-silver nanoparticles against Trichomonas vaginalis. Next Research. 2025:100620.
35. Norouzi R. A review on most nanoparticles applied against parasitic infections. J Biol Today’s World. 2017;6(10):196-203.
36. Mungroo MR, Anwar A, Khan NA, Siddiqui R. Gold-conjugated curcumin as a novel therapeutic agent against brain-eating amoebae. ACS Omega. 2020;5(21):12467-12475.
37. Soto-Sánchez J, Garza-Treviño G. Combination therapy and phytochemical-loaded nanosytems for the treatment of neglected tropical diseases. Pharmaceutics. 2024;16(10):1239.
| Files | ||
| Issue | Vol 21 No 4 (2026) | |
| Section | Original Article(s) | |
| Keywords | ||
| Gold nanoparticles Apigenin Trichomonas vaginalis Metronidazole In vitro | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |

